Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Aviva PLC

Aviva PLC decreased its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 34.1% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 70,153 shares of the biotechnology company’s stock after selling 36,226 shares during the quarter. Aviva PLC’s holdings in Axon Enterprise were worth $41,693,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Quantbot Technologies LP purchased a new position in shares of Axon Enterprise in the 3rd quarter valued at approximately $84,000. Townsquare Capital LLC acquired a new position in Axon Enterprise during the 3rd quarter worth approximately $261,000. Public Sector Pension Investment Board raised its stake in shares of Axon Enterprise by 19.2% during the 3rd quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock worth $1,240,000 after buying an additional 500 shares in the last quarter. Benjamin Edwards Inc. acquired a new stake in shares of Axon Enterprise in the 3rd quarter valued at approximately $1,098,000. Finally, Hilltop Holdings Inc. purchased a new stake in shares of Axon Enterprise in the third quarter valued at approximately $220,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Transactions at Axon Enterprise

In related news, Director Jeri Williams sold 307 shares of the firm’s stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the sale, the director now owns 1,627 shares in the company, valued at approximately $899,275.44. This trade represents a 15.87 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 6.10% of the company’s stock.

Analyst Upgrades and Downgrades

AXON has been the topic of a number of research analyst reports. JMP Securities reissued an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Barclays restated a “hold” rating on shares of Axon Enterprise in a report on Monday, March 10th. Northcoast Research cut Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday, February 19th. TD Cowen started coverage on Axon Enterprise in a report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 target price on the stock. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $600.00 price target on shares of Axon Enterprise in a research note on Wednesday, February 26th. One research analyst has rated the stock with a sell rating, two have given a hold rating and eleven have assigned a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $604.67.

Axon Enterprise Trading Down 7.9 %

Shares of AXON stock opened at $497.13 on Friday. Axon Enterprise, Inc. has a twelve month low of $273.52 and a twelve month high of $715.99. The company has a market capitalization of $38.09 billion, a price-to-earnings ratio of 128.46, a PEG ratio of 5.17 and a beta of 1.13. The firm has a 50-day moving average price of $582.26 and a 200 day moving average price of $554.66. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.